trial

Treating Smokers With Mental Illness

NCTId NCT03822416
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 38 (actual)
Sponsored by University of Minnesota
Primary completion 2020-05-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
38 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2019-03-01
Primary completion
2020-05-04
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Nicotine patchNicotine lozengeTherapyInformation

Sponsors

University of MinnesotaLead Sponsor
Hennepin County Medical Center, MinneapolisCollaborator
Brown UniversityCollaborator

Investigators

1
Harry Lando, PhDPrincipal Investigator

Sites

1 total
Minneapolis, United States

Linked catalysts

1
Treating Smokers With Mental Illness — primary completion2020-05-04

Facts & assertions

4 sourced
Enrollment
38
Phase
PHASE2
Primary Completion Date
2020-05-04
Status
COMPLETED
relationships
The graph out of here
drug
Nicotine patch
drug
Nicotine lozenge
drug
Therapy
drug
Information
drug
lead_sponsor
University of Minnesota
company
collaborator
Hennepin County Medical Center, Minneapolis
company
Brown University
company
indication
Bipolar Disorder
indication
Bipolar Disorder I
indication
Psychotic Disorders
indication
investigator
Harry Lando, PhD
person